These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24722171)

  • 61. Cardiovascular and Cerebrovascular Safety of Testosterone Replacement Therapy Among Aging Men with Low Testosterone Levels: A Cohort Study.
    Loo SY; Azoulay L; Nie R; Dell'Aniello S; Yu OHY; Renoux C
    Am J Med; 2019 Sep; 132(9):1069-1077.e4. PubMed ID: 30953635
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Androgens and coronary artery disease.
    Wu FC; von Eckardstein A
    Endocr Rev; 2003 Apr; 24(2):183-217. PubMed ID: 12700179
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Testosterone and risk factors for cardiovascular disease in men.
    Barrett-Connor EL
    Diabete Metab; 1995 Jun; 21(3):156-61. PubMed ID: 7556805
    [TBL] [Abstract][Full Text] [Related]  

  • 64. LDL-cholesterol lowering or HDL-cholesterol raising for cardiovascular prevention. A lesson from cholesterol turnover studies and others.
    Sirtori CR; Fumagalli R
    Atherosclerosis; 2006 May; 186(1):1-11. PubMed ID: 16310198
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effectiveness of testosterone therapy in hypogonadal patients and its controversial adverse impact on the cardiovascular system.
    Kharaba ZJ; Buabeid MA; Alfoteih YA
    Crit Rev Toxicol; 2020 Jul; 50(6):491-512. PubMed ID: 32689855
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association of Testosterone Replacement Therapy and the Incidence of a Composite of Postoperative In-Hospital Mortality and Cardiovascular Events in Men Undergoing Cardiac Surgery.
    Argalious MY; Steib J; Daskalakis N; Mao G; Li M; Armanyous S; Roselli E
    Anesth Analg; 2020 Apr; 130(4):890-898. PubMed ID: 30896595
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Controversies regarding the cardiovascular effects of testosterone replacement therapy in older men.
    Chrysant SG
    Drugs Today (Barc); 2018 Jan; 54(1):25-34. PubMed ID: 29569659
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis.
    Isidori AM; Giannetta E; Greco EA; Gianfrilli D; Bonifacio V; Isidori A; Lenzi A; Fabbri A
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):280-93. PubMed ID: 16117815
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Testosterone Therapy and Risk of Acute Myocardial Infarction in Hypogonadal Men: An Administrative Health Care Claims Study.
    Li H; Mitchell L; Zhang X; Heiselman D; Motsko S
    J Sex Med; 2017 Nov; 14(11):1307-1317. PubMed ID: 29110802
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Baricitinib induces LDL-C and HDL-C increases in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Qiu C; Zhao X; She L; Shi Z; Deng Z; Tan L; Tu X; Jiang S; Tang B
    Lipids Health Dis; 2019 Feb; 18(1):54. PubMed ID: 30777075
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Testosterone in older men after the Institute of Medicine Report: where do we go from here?
    Harman SM
    Climacteric; 2005 Jun; 8(2):124-35. PubMed ID: 16096168
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Testosterone and the Heart.
    Goodale T; Sadhu A; Petak S; Robbins R
    Methodist Debakey Cardiovasc J; 2017; 13(2):68-72. PubMed ID: 28740585
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In brief: testosterone and cardiovascular risk.
    Med Lett Drugs Ther; 2014 Mar; 56(1437):17. PubMed ID: 24589496
    [No Abstract]   [Full Text] [Related]  

  • 74. Testosterone treatment in the aging male: myth or reality?
    Nigro N; Christ-Crain M
    Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gender-related impact on outcomes of high density lipoprotein in acute ST-elevation myocardial infarction.
    Distelmaier K; Schrutka L; Wurm R; Seidl V; Arfsten H; Cho A; Manjunatha S; Perkmann T; Strunk G; Lang IM; Adlbrecht C
    Atherosclerosis; 2016 Aug; 251():460-466. PubMed ID: 27381657
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Risks of testosterone replacement therapy in ageing men.
    Tan RS; Salazar JA
    Expert Opin Drug Saf; 2004 Nov; 3(6):599-606. PubMed ID: 15500418
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Testosterone replacement, cardiovascular system and risk factors in the aging male.
    Vigna GB; Bergami E
    J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):69-74. PubMed ID: 16760629
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis.
    Corona G; Maseroli E; Rastrelli G; Isidori AM; Sforza A; Mannucci E; Maggi M
    Expert Opin Drug Saf; 2014 Oct; 13(10):1327-51. PubMed ID: 25139126
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A new testosterone gel (fortesta) for hypogonadism.
    Med Lett Drugs Ther; 2011 Apr; 53(1362):29-30. PubMed ID: 21502933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.